COURT OF CHANCERY OF THE STATE OF DELAWARE BONNIE W. DAVID COURT OF CHANCERY COURTHOUSE VICE CHANCELLOR 34 THE CIRCLE GEORGETOWN, DE 19947
Date Submitted: August 8, 2025 Date Decided: August 28, 2025
Peter B. Ladig, Esquire Marc S. Casarino, Esquire Emily L. Skaug, Esquire Katie Barksdale, Esquire BAYARD, P.A. KENNEDYS CMK LLP 600 N. King Street, Suite 400 222 Delaware Avenue, Suite 710 Wilmington, DE 19801 Wilmington, DE 19801
RE: Minnie Sarwal v. Nephrosant, Inc., C.A. No. 2023-0222-BWD
Dear Counsel:
This letter opinion resolves counterclaim-defendant Minnie Sarwal’s motion
to dismiss Count III of counterclaim-plaintiff Nephrosant, Inc.’s (“Nephrosant”)
Verified Counterclaims (the “Counterclaims”).
In this action, Sarwal seeks advancement and indemnification from
Nephrosant, a Delaware corporation headquartered in California that Sarwal
founded “to develop and monetize . . . a non-invasive urine test to identify the risk
of transplant rejection commercially known as QSant.” Verified Compl. ¶ 3, Dkt. 1.
Sarwal alleges that Nephrosant “steadily achieved success” under her leadership,
until investors with representation on the company’s board of directors ousted her
under the “artifice” of an internal investigation undertaken to “justify freezing Minnie Sarwal v. Nephrosant, Inc., C.A. No. 2023-0222-BWD August 28, 2025 Page 2 of 7
[Sarwal] out” of the company. Id. ¶¶ 1, 8. In early 2022, the board removed Sarwal
as CEO and appointed non-party Mark Capone as Nephrosant’s new CEO, then
established a committee of directors (the “Special Committee”) to investigate
“complaints from unnamed employees” about assays used in the company’s QSant
product. Id. ¶¶ 12–13, 15. The Special Committee directed Sarwal to remain home
during the investigation. Id. ¶ 17. After the investigation, Capone placed Sarwal on
administrative leave and suspended her access to the company’s servers and email.
Id. ¶ 20. Sarwal asserts that she “cooperat[ed] fully with” the investigation, which
“found no wrongdoing by her,” and is entitled to indemnification of fees and
expenses incurred in responding to the investigation. Id. ¶¶ 22, 25, 28.
Nephrosant denies that Sarwal is entitled to advancement or indemnification
in connection with the investigation. In its Counterclaims, Nephrosant alleges that
when Sarwal was asked to provide documents during the Special Committee’s
investigation, she used an email account associated with the University of California,
San Francisco School of Medicine to access, download, and delete tens of thousands
of confidential company documents stored in a Box account. Def. Nephrosant, Inc.’s
Answer and Verified Countercls. to Pl.’s Verified Compl. [hereinafter Countercls.]
¶¶ 26–27, 34, Dkt. 9. Count III of the Counterclaims asserts a statutory tort claim
against Sarwal under the Delaware Computer Related Offenses Act, 11 Del. C. Minnie Sarwal v. Nephrosant, Inc., C.A. No. 2023-0222-BWD August 28, 2025 Page 3 of 7
§§ 931–941 (the “Act”), which criminalizes certain computer-related conduct and
creates a private cause of action for individuals aggrieved by such conduct.1
Sarwal has moved to dismiss Count III of the Counterclaims for failure to state
a claim under Court of Chancery Rule 12(b)(6). When reviewing a motion to dismiss
under Rule 12(b)(6), Delaware courts “(1) accept all well pleaded factual allegations
as true, (2) accept even vague allegations as ‘well pleaded’ if they give the opposing
party notice of the claim, [and] (3) draw all reasonable inferences in favor of the
non-moving party . . . .” Central Mortg. Co. v. Morgan Stanley Mortg. Capital
Holdings LLC, 27 A.3d 531, 535 (Del. 2011) (citing Savor, Inc. v. FMR Corp., 812
A.2d 894, 896–97 (Del. 2002)).
Sarwal contends that Count III must be dismissed because it is not reasonably
conceivable that the Act could govern Nephrosant’s computer-related claims. I
agree. Although Nephrosant has attempted to sue under the Act, that statute lacks
1 Section 941 provides, in relevant part, that “any person who suffers any injury to person, business or property may bring an action for damages against a person who is alleged to have violated any provision of §§ 932–938 of this title,” regardless of whether the State has filed criminal charges against that person for the alleged computer crime. 11 Del. C. § 941(c). Sections 932 through 938 identify several computer-related offenses, including “theft of computer services” (Section 933), “interruption of computer services” (Section 934), and “misuse of computer system information” (Section 935). Id. §§ 932–938. Section 940 establishes proper venue. Id. § 940. Minnie Sarwal v. Nephrosant, Inc., C.A. No. 2023-0222-BWD August 28, 2025 Page 4 of 7
extraterritorial effect. Title 11, Section 204(a) of the Delaware Code addresses the
territorial applicability of the Act:
Except as otherwise provided in this section a person may be convicted under the law of this State of an offense committed by the person’s own conduct or by the conduct of another for which the person is legally accountable if:
(1) Either the conduct or the result which is an element of the offense occurs within Delaware; or
(2) Conduct occurring outside the State is sufficient under Delaware law to constitute a conspiracy to commit an offense within the State and an overt act in furtherance of the conspiracy occurs within the State; or
(3) Conduct occurring within the State establishes complicity in the commission of, or an attempt, solicitation or conspiracy to commit, an offense in another jurisdiction which also is an offense under the law of Delaware; or
(4) The offense consists of the omission to perform a legal duty imposed by Delaware law with respect to domicile, residence or a relationship to a person, thing or transaction in the State; or
(5) The offense is based on a statute of Delaware which expressly prohibits conduct outside the State, when the conduct bears a reasonable relation to a legitimate interest of this State and the defendant knows or should know that the defendant’s conduct is likely to affect that interest.
11 Del. C. § 204(a).
The Counterclaims do not allege that any conduct or result took place in
Delaware. Instead, the Counterclaims allege that Sarwal, while located in Minnie Sarwal v. Nephrosant, Inc., C.A. No. 2023-0222-BWD August 28, 2025 Page 5 of 7
California, accessed and deleted company files using IP addresses associated with
the University of California, San Francisco. Countercls. ¶¶ 26–27, 34. The
Counterclaims likewise do not allege that the computer systems at issue were located
in Delaware. Nephrosant argues that the Act nevertheless applies because Sarwal
“intentionally accessed and deleted [the] proprietary information” of a Delaware
corporation.2 Def. Countercl. Pl. Nephrosant, Inc.’s Answering Br. in Opp’n to Pl.’s
Mot. to Dismiss Count III of the Countercls. [hereinafter AB] at 3, Dkt. 120. But
Nephrosant “has not cited, and research has not revealed, any decision that uses the
state of incorporation of the plaintiff as a controlling, predominant, or even weighty
factor when determining what law governs a claim for” computer-related offenses.
Focus Fin. Partners, LLC v. Holsopple, 250 A.3d 939, 970 (Del. Ch. 2020) (holding
it was not reasonably conceivable that the Delaware Uniform Trade Secrets Act
Free access — add to your briefcase to read the full text and ask questions with AI
COURT OF CHANCERY OF THE STATE OF DELAWARE BONNIE W. DAVID COURT OF CHANCERY COURTHOUSE VICE CHANCELLOR 34 THE CIRCLE GEORGETOWN, DE 19947
Date Submitted: August 8, 2025 Date Decided: August 28, 2025
Peter B. Ladig, Esquire Marc S. Casarino, Esquire Emily L. Skaug, Esquire Katie Barksdale, Esquire BAYARD, P.A. KENNEDYS CMK LLP 600 N. King Street, Suite 400 222 Delaware Avenue, Suite 710 Wilmington, DE 19801 Wilmington, DE 19801
RE: Minnie Sarwal v. Nephrosant, Inc., C.A. No. 2023-0222-BWD
Dear Counsel:
This letter opinion resolves counterclaim-defendant Minnie Sarwal’s motion
to dismiss Count III of counterclaim-plaintiff Nephrosant, Inc.’s (“Nephrosant”)
Verified Counterclaims (the “Counterclaims”).
In this action, Sarwal seeks advancement and indemnification from
Nephrosant, a Delaware corporation headquartered in California that Sarwal
founded “to develop and monetize . . . a non-invasive urine test to identify the risk
of transplant rejection commercially known as QSant.” Verified Compl. ¶ 3, Dkt. 1.
Sarwal alleges that Nephrosant “steadily achieved success” under her leadership,
until investors with representation on the company’s board of directors ousted her
under the “artifice” of an internal investigation undertaken to “justify freezing Minnie Sarwal v. Nephrosant, Inc., C.A. No. 2023-0222-BWD August 28, 2025 Page 2 of 7
[Sarwal] out” of the company. Id. ¶¶ 1, 8. In early 2022, the board removed Sarwal
as CEO and appointed non-party Mark Capone as Nephrosant’s new CEO, then
established a committee of directors (the “Special Committee”) to investigate
“complaints from unnamed employees” about assays used in the company’s QSant
product. Id. ¶¶ 12–13, 15. The Special Committee directed Sarwal to remain home
during the investigation. Id. ¶ 17. After the investigation, Capone placed Sarwal on
administrative leave and suspended her access to the company’s servers and email.
Id. ¶ 20. Sarwal asserts that she “cooperat[ed] fully with” the investigation, which
“found no wrongdoing by her,” and is entitled to indemnification of fees and
expenses incurred in responding to the investigation. Id. ¶¶ 22, 25, 28.
Nephrosant denies that Sarwal is entitled to advancement or indemnification
in connection with the investigation. In its Counterclaims, Nephrosant alleges that
when Sarwal was asked to provide documents during the Special Committee’s
investigation, she used an email account associated with the University of California,
San Francisco School of Medicine to access, download, and delete tens of thousands
of confidential company documents stored in a Box account. Def. Nephrosant, Inc.’s
Answer and Verified Countercls. to Pl.’s Verified Compl. [hereinafter Countercls.]
¶¶ 26–27, 34, Dkt. 9. Count III of the Counterclaims asserts a statutory tort claim
against Sarwal under the Delaware Computer Related Offenses Act, 11 Del. C. Minnie Sarwal v. Nephrosant, Inc., C.A. No. 2023-0222-BWD August 28, 2025 Page 3 of 7
§§ 931–941 (the “Act”), which criminalizes certain computer-related conduct and
creates a private cause of action for individuals aggrieved by such conduct.1
Sarwal has moved to dismiss Count III of the Counterclaims for failure to state
a claim under Court of Chancery Rule 12(b)(6). When reviewing a motion to dismiss
under Rule 12(b)(6), Delaware courts “(1) accept all well pleaded factual allegations
as true, (2) accept even vague allegations as ‘well pleaded’ if they give the opposing
party notice of the claim, [and] (3) draw all reasonable inferences in favor of the
non-moving party . . . .” Central Mortg. Co. v. Morgan Stanley Mortg. Capital
Holdings LLC, 27 A.3d 531, 535 (Del. 2011) (citing Savor, Inc. v. FMR Corp., 812
A.2d 894, 896–97 (Del. 2002)).
Sarwal contends that Count III must be dismissed because it is not reasonably
conceivable that the Act could govern Nephrosant’s computer-related claims. I
agree. Although Nephrosant has attempted to sue under the Act, that statute lacks
1 Section 941 provides, in relevant part, that “any person who suffers any injury to person, business or property may bring an action for damages against a person who is alleged to have violated any provision of §§ 932–938 of this title,” regardless of whether the State has filed criminal charges against that person for the alleged computer crime. 11 Del. C. § 941(c). Sections 932 through 938 identify several computer-related offenses, including “theft of computer services” (Section 933), “interruption of computer services” (Section 934), and “misuse of computer system information” (Section 935). Id. §§ 932–938. Section 940 establishes proper venue. Id. § 940. Minnie Sarwal v. Nephrosant, Inc., C.A. No. 2023-0222-BWD August 28, 2025 Page 4 of 7
extraterritorial effect. Title 11, Section 204(a) of the Delaware Code addresses the
territorial applicability of the Act:
Except as otherwise provided in this section a person may be convicted under the law of this State of an offense committed by the person’s own conduct or by the conduct of another for which the person is legally accountable if:
(1) Either the conduct or the result which is an element of the offense occurs within Delaware; or
(2) Conduct occurring outside the State is sufficient under Delaware law to constitute a conspiracy to commit an offense within the State and an overt act in furtherance of the conspiracy occurs within the State; or
(3) Conduct occurring within the State establishes complicity in the commission of, or an attempt, solicitation or conspiracy to commit, an offense in another jurisdiction which also is an offense under the law of Delaware; or
(4) The offense consists of the omission to perform a legal duty imposed by Delaware law with respect to domicile, residence or a relationship to a person, thing or transaction in the State; or
(5) The offense is based on a statute of Delaware which expressly prohibits conduct outside the State, when the conduct bears a reasonable relation to a legitimate interest of this State and the defendant knows or should know that the defendant’s conduct is likely to affect that interest.
11 Del. C. § 204(a).
The Counterclaims do not allege that any conduct or result took place in
Delaware. Instead, the Counterclaims allege that Sarwal, while located in Minnie Sarwal v. Nephrosant, Inc., C.A. No. 2023-0222-BWD August 28, 2025 Page 5 of 7
California, accessed and deleted company files using IP addresses associated with
the University of California, San Francisco. Countercls. ¶¶ 26–27, 34. The
Counterclaims likewise do not allege that the computer systems at issue were located
in Delaware. Nephrosant argues that the Act nevertheless applies because Sarwal
“intentionally accessed and deleted [the] proprietary information” of a Delaware
corporation.2 Def. Countercl. Pl. Nephrosant, Inc.’s Answering Br. in Opp’n to Pl.’s
Mot. to Dismiss Count III of the Countercls. [hereinafter AB] at 3, Dkt. 120. But
Nephrosant “has not cited, and research has not revealed, any decision that uses the
state of incorporation of the plaintiff as a controlling, predominant, or even weighty
factor when determining what law governs a claim for” computer-related offenses.
Focus Fin. Partners, LLC v. Holsopple, 250 A.3d 939, 970 (Del. Ch. 2020) (holding
it was not reasonably conceivable that the Delaware Uniform Trade Secrets Act
applied to a claim for misappropriation of trade secrets where the plaintiff did not
“cite[] any conduct that took place in Delaware”); see also Vichi v. Koninklijke
Philips Elecs. N.V., 2009 WL 4345724, at *19 (Del. Ch. Dec. 1, 2009) (holding the
2 Much of Nephrosant’s briefing addresses personal jurisdiction over Sarwal. Those arguments miss the mark. Sarwal does not contend that the Court lacks personal jurisdiction over her; rather, she argues that Count III does not state a reasonably conceivable claim under the Act because the Act does not apply to conduct that exclusively occurred outside of Delaware. Minnie Sarwal v. Nephrosant, Inc., C.A. No. 2023-0222-BWD August 28, 2025 Page 6 of 7
Delaware Securities Act did not apply where there was not “a sufficient nexus
between Delaware and the transaction” as “the only Delaware connection in th[e]
matter [wa]s the Delaware organization of [the company]”).
Nephrosant also argues that Section 204(a)(5) “allows for extraterritorial
application when the conduct bears a reasonable relation to Delaware’s legitimate
interests.” AB at 7. In fact, Section 204(a)(5) provides that a person may be
convicted under the Act if “[t]he offense is based on a statute of Delaware which
expressly prohibits conduct outside the State, when the conduct bears a reasonable
relation to a legitimate interest of this State and the defendant knows or should know
that the defendant’s conduct is likely to affect that interest.” 11 Del. C. § 204(a)(5)
(emphasis added). Sections 933, 934, and 935 of the Act do not expressly prohibit
conduct outside the State.3 Section 204(a)(5) therefore does not apply.
3 Notably, Section 940(a) provides that “[i]n any prosecution for any violation of §§ 932– 938 of this title, the offense shall be deemed to have been committed in the place at which the act occurred or in which the computer system or part thereof involved in the violation was located[,]” and Section 940(c) states that “[i]f any act performed in furtherance of the offenses set out in §§ 932–938 of this title occurs in this State or if any computer system or part thereof accessed in violation of §§ 932–936 of this title is located in this State, the offense shall be deemed to have occurred in this State.” 11 Del. C. §§ 940(a), (c). Again, the Counterclaims do not allege that the computer systems involved in the violations were located in Delaware or that any act in furtherance of the violations occurred in Delaware. Minnie Sarwal v. Nephrosant, Inc., C.A. No. 2023-0222-BWD August 28, 2025 Page 7 of 7
Because the Counterclaims fail to state a reasonably conceivable claim under
the Act, the Motion is GRANTED and Count III is DISMISSED.
Sincerely,
/s/ Bonnie W. David
Bonnie W. David Vice Chancellor
cc: All counsel of record (by File & ServeXpress)